celecoxib has been researched along with uric acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blumenthal, RD; Burton, J; Flefleh, C; Goldenberg, DM; Lew, W; Waskewich, C | 1 |
Lai, R; Liang, Z; Liao, P; Wang, S; Xie, Z; Ye, Z; Zeng, L | 1 |
2 other study(ies) available for celecoxib and uric acid
Article | Year |
---|---|
Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts.
Topics: Animals; Antineoplastic Agents; Aspartate Aminotransferases; Bilirubin; Blood Urea Nitrogen; Blotting, Western; Body Weight; Breast Neoplasms; Celecoxib; Chronotherapy; Cyclooxygenase 2; Female; Humans; Isoenzymes; Mammary Neoplasms, Experimental; Membrane Proteins; Mice; Mice, Nude; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Sulfonamides; Survival Rate; Time Factors; Treatment Outcome; Uric Acid; Xenograft Model Antitumor Assays | 2001 |
Impacts of a Specific Cyclooxygenase-2 Inhibitor on Pressure Overload-Induced Myocardial Hypertrophy in Rats.
Topics: Animals; C-Reactive Protein; Cardiomegaly; Celecoxib; Cyclooxygenase 2 Inhibitors; Diet; Dinoprostone; Disease Models, Animal; Drug Administration Schedule; Heart; Male; Organ Size; Random Allocation; Rats, Sprague-Dawley; Receptors, Transforming Growth Factor beta; Smad1 Protein; Smad2 Protein; Smad3 Protein; Tumor Necrosis Factor-alpha; Uric Acid | 2019 |